Continuous Passive Motion Device Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

Continuous Passive Motion Devices Market Summary
Introduction
Continuous Passive Motion (CPM) devices are rehabilitation tools that promote joint mobility post-surgery, particularly for knee replacements (over 1 million annually worldwide) and conditions like osteoarthritis (affecting 500 million people). The market is driven by rising orthopedic surgeries, an aging population prone to joint issues (2.1 billion over 60 by 2050), and increasing trauma from sports injuries. Clinical evidence supports CPM’s benefits in early recovery, while innovations like IoT and lightweight designs improve compliance. The global market is projected to reach between USD 410 million and USD 650 million in 2025, with a CAGR of 4.2% to 6.5% through 2030.

Regional Analysis
North America: The U.S. leads with high knee replacement rates, while Canada focuses on elderly rehabilitation.
Europe: Germany, France, and the UK drive demand due to aging populations and orthopedic care.
Asia Pacific: China and India see growth from rising joint surgeries, while Japan emphasizes elderly mobility.
Rest of the World: Brazil expands orthopedic access, and the Middle East invests in rehab technologies.

Application Analysis
Children (Below 18): Expected growth of 4.0%-6.3%, driven by injury recovery. Trends focus on adjustable designs.
Adult (18 and above): Projected growth of 4.3%-6.6%, linked to surgery and arthritis. Developments emphasize home use.

Type Analysis
Knee Joint CPM Devices: Expected growth of 4.4%-6.7%, valued for high demand. Trends highlight smart programming.
Shoulder Joint CPM Devices: Projected growth of 4.1%-6.4%, key for mobility. Advances focus on versatility.
Hip Joint CPM Devices: Anticipated growth of 4.0%-6.3%, suited for post-surgical care. Innovations emphasize comfort.
Ankle Joint CPM Devices: Expected growth of 3.9%-6.2%, driven by injuries. Trends lean toward portability.
Others: Projected growth of 3.8%-6.1%, covering niche joints. Advances focus on customization.

Key Market Players
Leading firms include Kinex Medical Company, offering rehab solutions; Enovis, advancing CPM tech; Surgi-Care, supporting orthopedics; Furniss Corporation, focusing on mobility; Chinesport, developing rehab devices; BTL Corporate, enhancing therapy tools; Bio-Med International, targeting recovery; Biodex, launching SpaceTek; Kinetec, specializing in CPM; and HMS Medical Systems, introducing KNEEFLEX.

Porter's Five Forces Analysis
Threat of New Entrants: Moderate, due to regulatory and manufacturing barriers, though niche innovators can enter.
Threat of Substitutes: Moderate, with manual therapy as an option, though CPM offers unique benefits.
Bargaining Power of Buyers: Moderate, with patients seeking effective, affordable devices, though clinical needs limit options.
Bargaining Power of Suppliers: Low, with multiple component providers.
Competitive Rivalry: High, with competition on portability, smart features, and cost efficiency.

Market Opportunities and Challenges
Opportunities:
Knee replacements (over 1 million annually) and osteoarthritis (500 million cases) drive demand.
Aging populations (2.1 billion over 60 by 2050) and injuries boost needs, while portable CPM devices support home rehab.
Smart technology enhances therapy outcomes.
Challenges:
High costs of advanced devices limit adoption in low-income regions.
Limited awareness in developing markets slows growth.
Reimbursement inconsistencies pose barriers.

Market News
In November 2023, Salona Global (soon Evome Medical Technologies) launched Biodex SpaceTek Knee Device, a portable CPM developed with NASA.
In March 2023, HMS Medical Systems introduced KNEEFLEX Es CPM, enhancing knee recovery with advanced algorithms.